Prurigo Nodularis
Symptoms, Doctors, Treatments, Advances & More

Prurigo Nodularis Overview

Save information for later
Sign Up

Learn About Prurigo Nodularis

What is the definition of Prurigo Nodularis?
Prurigo nodularis (PN) is a skin disease that causes hard, itchy lumps (nodules) to form on the skin. The itching (pruritus) can be intense, causing people to scratch themselves to the point of bleeding or pain. Scratching can cause more skin lesions to appear. In some cases, people with PN have a history of other diseases including eczema (atopic dermatitis), lymphoma, HIV infection, severe anemia, or kidney disease. The exact cause of PN is unknown. Although scratching is known to cause more nodules to appear, it is unclear what causes the itching to develop in the first place. Diagnosis of the disease is based on observing signs such as extremely itchy skin with the formation of nodules. In some cases, a skin biopsy is used to confirm the diagnosis.
What are the alternative names for Prurigo Nodularis?
  • Prurigo nodularis
  • Nodular prurigo
Who are the top Prurigo Nodularis Local Doctors?
Elite in Prurigo Nodularis
Elite in Prurigo Nodularis
Referral may be required
Before you request

University Of Maryland Dermatology Paca Redwood Suite 260

419 West Redwood Street, Suite 260, 
Baltimore, MD 
667-214-1171
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Shawn Kwatra is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Kwatra is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Atopic Dermatitis, Lichen Simplex Chronicus, and Actinic Keratosis. Dr. Kwatra is board certified in American Board Of Dermatology - Dermatology, 2017. Dr. Kwatra is currently accepting new patients.

Elite in Prurigo Nodularis
Dr. Joseph A. Zahn
Dermatology
Elite in Prurigo Nodularis
Dr. Joseph A. Zahn
Dermatology
Referral may be required
Before you request

GW The Medical Faculty Associate

2150 Pennsylvania Ave NW, 
Washington, DC 
202-741-2600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Zahn is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Zahn is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Squamous Cell Skin Carcinoma, Atopic Dermatitis, and Bowen's Disease. Dr. Zahn is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Prurigo Nodularis
Elite in Prurigo Nodularis
Referral may be required
Before you request

Mass General Bulfinch Medical Group

50 Staniford St, 
Boston, MA 
617-726-2914
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Yevgeniy Semenov is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Semenov is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Melanoma, Lichen Simplex Chronicus, and Vitiligo. Dr. Semenov is currently accepting new patients.

View All Doctors
What are the latest Prurigo Nodularis Clinical Trials?
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Enrollment Status: Recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

Match to trials
Find the right clinical trials for you in under a minute
Get started
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Enrollment Status: Recruiting
Publish Date: June 01, 2026

Summary: The main aim of this study is to assess real-world effectiveness of nemolizumab in Prurigo nodularis (PN) as measured by investigator and patient reported outcome (PRO) in clinical practice at Month 6.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center